Age at index date, yrs, mean ± SD | 54.6 ± 15.0 | 54.5 ± 14.9 | 0.84 |
Length of followup, yrs, median (range) | 10.5 (0.02–45.7) | 12.5 (0.01–47.3) | — |
Female sex | 739 (71) | 744 (72) | 0.75 |
White race | 959 (93) | 967 (94) | 0.39 |
Current smoker at incidence/index date | 261 (25) | 221 (21) | 0.04 |
Diabetes mellitus | | | |
At incidence/index date | 81 (8) | 60 (6) | 0.07 |
Evera | 193 (25) | 198 (28) | 0.99 |
Hypertension | | | |
At incidence/index date | 586 (57) | 476 (46) | < 0.001 |
Evera | 877 (92) | 777 (89) | < 0.001 |
Dyslipidemia | | | |
At incidence/index date | 410 (40) | 354 (34) | 0.012 |
Evera | 654 (69) | 687 (78) | 0.054 |
Obesity | | | |
At incidence/index date | 319 (31) | 265 (26) | 0.009 |
Evera | 398 (41) | 389 (42) | 0.70 |
Prior major osteoporotic fracture | 89 (9) | 99 (10) | 0.44 |
RF positivity | 675 (67) | — | |
Erosionsb | 269 (26) | — | |
Nodulesb | 163 (16) | — | |
Evera glucocorticoids | 706 (68) | — | |
Evera hormone replacement therapy | 284 (27) | — | |